Resultados de búsqueda - Szlosarek, Peter

Recent advances in palliative care: United Kingdom continues to lead in palliative care por Szlosarek, Peter W

Enlace del recurso Enlace del recurso

Arginine deprivation and autophagic cell death in cancer por Szlosarek, Peter Wojciech

Enlace del recurso Enlace del recurso Enlace del recurso

Optimizing arginine deprivation for hard-to-treat cancers por Khadeir, Ramsay, Szyszko, Teresa, Szlosarek, Peter W.

Enlace del recurso Enlace del recurso Enlace del recurso

Targeting Arginine-Dependent Cancers with Arginine-Degrading Enzymes: Opportunities and Challenges por Phillips, Melissa M., Sheaff, Michael T., Szlosarek, Peter W.

Enlace del recurso Enlace del recurso Enlace del recurso

Small vessel vasculitis and dry gangrene secondary to combined CTLA-4 and PD-1 blockade in malignant mesothelioma por Kefas, Joanna, Harwood, Catherine, Lewis, Myles J., Szlosarek, Peter

Enlace del recurso Enlace del recurso Enlace del recurso

Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma por Karydis, Ioannis, Chan, Pui Ying, Wheater, Matthew, Arriola, Edurne, Szlosarek, Peter W., Ottensmeier, Christian H.

Enlace del recurso Enlace del recurso Enlace del recurso

Staging Uveal Melanoma with Whole-Body Positron-Emission Tomography/Computed Tomography and Abdominal Ultrasound: Low Incidence of Metastatic Disease, High Incidence of Second Prim... por Cohen, Victoria M. L., Pavlidou, Efthymia, DaCosta, Joanna, Arora, Amit K., Szyszko, Teressa, Sagoo, Mandeep S., Szlosarek, Peter

Enlace del recurso Enlace del recurso Enlace del recurso

Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells por Zheng, Liang, MacKenzie, Elaine D, Karim, Saadia A, Hedley, Ann, Blyth, Karen, Kalna, Gabriela, Watson, David G, Szlosarek, Peter, Frezza, Christian, Gottlieb, Eyal

Enlace del recurso Enlace del recurso Enlace del recurso

Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20) por Burrows, Natalie, Cane, Gaelle, Robson, Mathew, Gaude, Edoardo, J. Howat, William, Szlosarek, Peter W., Pedley, R. Barbara, Frezza, Christian, Ashcroft, Margaret, Maxwell, Patrick H.

Enlace del recurso Enlace del recurso Enlace del recurso

Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1 por Locke, Matthew, Ghazaly, Essam, Freitas, Marta O., Mitsinga, Mikaella, Lattanzio, Laura, Lo Nigro, Cristiana, Nagano, Ai, Wang, Jun, Chelala, Claude, Szlosarek, Peter, Martin, Sarah A.

Enlace del recurso Enlace del recurso Enlace del recurso

A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1‐negative metastatic uveal melanoma por Chan, Pui Ying, Phillips, Melissa M., Ellis, Stephen, Johnston, Amanda, Feng, Xiaoxing, Arora, Amit, Hay, Gordon, Cohen, Victoria M. L., Sagoo, Mandeep S., Bomalaski, John S., Sheaff, Michael T., Szlosarek, Peter W.

Enlace del recurso Enlace del recurso Enlace del recurso

Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM por Przystal, Justyna Magdalena, Hajji, Nabil, Khozoie, Combiz, Renziehausen, Alexander, Zeng, Qingyu, Abaitua, Fernando, Hajitou, Amin, Suwan, Keittisak, Want, Elizabeth, Bomalaski, John, Szlosarek, Peter, O’Neill, Kevin, Crook, Tim, Syed, Nelofer

Enlace del recurso Enlace del recurso Enlace del recurso

Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1–Deficient Mesothelioma: Safety, Efficacy, and Resistance Mech... por Szlosarek, Peter W., Phillips, Melissa M., Pavlyk, Iuliia, Steele, Jeremy, Shamash, Jonathan, Spicer, James, Kumar, Sanjeev, Pacey, Simon, Feng, Xiaoxing, Johnston, Amanda, Bomalaski, John, Moir, Graeme, Lau, Kelvin, Ellis, Stephen, Sheaff, Michael

Enlace del recurso Enlace del recurso Enlace del recurso

CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised c... por Fennell, Dean A., Kirkpatrick, Emma, Cozens, Kelly, Nye, Mavis, Lester, Jason, Hanna, Gerard, Steele, Nicola, Szlosarek, Peter, Danson, Sarah, Lord, Joanne, Ottensmeier, Christian, Barnes, Daniel, Hill, Stephanie, Kalevras, Mihalis, Maishman, Tom, Griffiths, Gareth

Enlace del recurso Enlace del recurso Enlace del recurso

Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1–Deficient Thoracic Cancers por Beddowes, Emma, Spicer, James, Chan, Pui Ying, Khadeir, Ramsay, Corbacho, Javier Garcia, Repana, Dimitra, Steele, Jeremy P., Schmid, Peter, Szyszko, Teresa, Cook, Gary, Diaz, Monica, Feng, Xiaoxing, Johnston, Amanda, Thomson, Jim, Sheaff, Michael, Wu, Bor-Wen, Bomalaski, John, Pacey, Simon, Szlosarek, Peter W.

Enlace del recurso Enlace del recurso Enlace del recurso

A PHASE I EXPANSION STUDY OF PEGARGIMINASE, CISPLATIN AND PEMETREXED IN ARGININOSUCCINATE SYNTHETASE 1-NEGATIVE RECURRENT HIGH GRADE GLIOMAS (HGGS) por Hall, Peter, Lewis, Rachel, Syed, Nelofer, Shaffer, Richard, Evanson, Jane, Ellis, Stephen, Williams, Matthew, Feng, Xiaoxing, Johnston, Amanda, Thomson, Jim, Harris, Fiona, Jena, Raj, Jefferies, Sarah, Khadeir, Ramsay, Wu, Bor-Wen, Bomalaski, John, Crook, Timothy, Sheaff, Michael, Pacey, Simon, Plowman, Nick, Szlosarek, Peter

Enlace del recurso Enlace del recurso

Phase 1, pharmacogenomic, dose‐expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1‐deficient non‐squamous non‐small cell lung cancer por Szlosarek, Peter W., Wimalasingham, Akhila G., Phillips, Melissa M., Hall, Peter E., Chan, Pui Ying, Conibear, John, Lim, Louise, Rashid, Sukaina, Steele, Jeremy, Wells, Paula, Shiu, Chiung‐Fang, Kuo, Chih‐Ling, Feng, Xiaoxing, Johnston, Amanda, Bomalaski, John, Ellis, Stephen, Grantham, Marianne, Sheaff, Michael

Enlace del recurso Enlace del recurso Enlace del recurso

Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial por Fennell, Dean A, Ewings, Sean, Ottensmeier, Christian, Califano, Raffaele, Hanna, Gerard G, Hill, Kayleigh, Danson, Sarah, Steele, Nicola, Nye, Mavis, Johnson, Lucy, Lord, Joanne, Middleton, Calley, Szlosarek, Peter, Chan, Sam, Gaba, Aarti, Darlison, Liz, Wells-Jordan, Peter, Richards, Cathy, Poile, Charlotte, Lester, Jason F, Griffiths, Gareth

Enlace del recurso Enlace del recurso Enlace del recurso

Collagen Prolyl Hydroxylases Are Bifunctional Growth Regulators in Melanoma por Atkinson, Aithne, Renziehausen, Alexander, Wang, Hexiao, Lo Nigro, Cristiana, Lattanzio, Laura, Merlano, Marco, Rao, Bhavya, Weir, Lynda, Evans, Alan, Matin, Rubeta, Harwood, Catherine, Szlosarek, Peter, Pickering, J Geoffrey, Fleming, Colin, Sim, Van Ren, Li, Su, Vasta, James T., Raines, Ronald T., Boniol, Mathieu, Thompson, Alastair, Proby, Charlotte, Crook, Tim, Syed, Nelofer

Enlace del recurso Enlace del recurso Enlace del recurso

Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers por Chang, Kwang-Yu, Chiang, Nai-Jung, Wu, Shang-Yin, Yen, Chia-Jui, Chen, Shang-Hung, Yeh, Yu-Min, Li, Chien-Feng, Feng, Xiaoxing, Wu, Katherine, Johnston, Amanda, Bomalaski, John S., Wu, Bor-Wen, Gao, Jianjun, Subudhi, Sumit K., Kaseb, Ahmed O., Blando, Jorge M., Yadav, Shalini S., Szlosarek, Peter W., Chen, Li-Tzong

Enlace del recurso Enlace del recurso Enlace del recurso